ReviewStroke research and treatment2016
Systematic Review of Hospital Readmissions in Stroke Patients.
Review in Stroke research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- Factors associated with post-stroke readmission: a systematic review and meta analysis.Scientific reports · 2025Pooled it
- Interventions to reduce readmissions after pneumonia hospitalization: A systematic review and meta-analysis.Journal of hospital medicine · 2025Pooled it
- Rate and key predictors of unplanned readmission following ischemic stroke: a systematic review and meta-analysis.Frontiers in neurologyPooled it
- Hospital Readmissions and Mortality Among Fee-for-Service Medicare Patients With Minor Stroke or Transient Ischemic Attack: Findings From the COMPASS Cluster-Randomized Pragmatic Trial.Journal of the American Heart Association · 2021Trial
- Article
- Readmission After Ischemic Stroke in Ningxia, China, From 2017 to 2021: Retrospective Cohort Study.Interactive journal of medical research · 2025Article
- Stroke Discharge Care Navigation: A Compass in Need of a Captain.Stroke (Hoboken, N.J.) · 2025Article
- Identifying determinants of readmission and death post-stroke using explainable machine learning.PloS one · 2025Observational
- Sarcopenia as a Robust Predictor of Readmission within 6 Months among Individuals Experiencing Acute Stroke.Annals of geriatric medicine and research · 2024Article
- Rapid systematic review of readmissions costs after stroke.Cost effectiveness and resource allocation : C/E · 2024Review
- Stroke Subtype and Risk of Subsequent Hospitalization: The Atherosclerosis Risk in Communities StudyNeurology · 2024Article
- Readmission and mortality during the first year after an acute stroke: A prospective cohort study from Cameroon.PloS one · 2024Article
- High Risk Features Contributing to 30-Day Readmission After Acute Ischemic Stroke: A Single Center Retrospective Case-Control Study.The Neurohospitalist · 2022Article
- Association between the LACE+ index and unplanned 30-day hospital readmissions in hospitalized patients with stroke.Frontiers in neurology · 2022Article
- Combined Functional Assessment for Predicting Clinical Outcomes in Stroke Patients After Post-acute Care: A Retrospective Multi-Center Cohort in Central Taiwan.Frontiers in aging neuroscience · 2022Article
- Perioperative Stroke and Thirty-Day Hospital Readmission After Cardiac Surgeries: State Inpatient Database Study.Journal of clinical medicine research · 2022Article
- Use of health and aged care services in Australia following hospital admission for myocardial infarction, stroke or heart failure.BMC geriatrics · 2021Article
- Hospital readmission in stroke survivors one year versus three years after discharge from inpatient rehabilitation: Prevalence and associations in an Asian cohort.Journal of rehabilitation medicine · 2021Article
- Pre-stroke disability and stroke severity as predictors of discharge destination from an acute stroke ward.Clinical medicine (London, England) · 2021Article
- Admission and Readmission/Death Patterns in Hospitalized and Non-hospitalized First-Ever-in-a-Lifetime Stroke Patients During the First Year: A Population-Based Incidence Study.Frontiers in neurology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background. Previous evidence on factors and causes of readmissions associated with high-impact users of stroke is scanty. The aim of the study was to investigate common causes and pattern of short- and long-term readmissions stroke patients by conducting a systematic review of studies using hospital administrative data. Common risk factors associated with the change of readmission rate were also examined. Methods. The literature search was conducted from 15 February to 15 March 2016 using various databases, such as Medline, Embase, and Web of Science. Results. There were a total of 24 studies (n = 2,126,617) included in the review. Only 4 studies assessed causes of readmissions in stroke patients with the follow-up duration from 30 days to 5 years. Common causes of readmissions in majority of the studies were recurrent stroke, infections, and cardiac conditions. Common patient-related risk factors associated with increased readmission rate were age and history of coronary heart disease, heart failure, renal disease, respiratory disease, peripheral arterial disease, and diabetes. Among stroke-related factors, length of stay of index stroke admission was associated with increased readmission rate, followed by bowel incontinence, feeding tube, and urinary catheter. Conclusion. Although risk factors and common causes of readmission were identified, none of the previous studies investigated causes and their sequence of readmissions among high-impact stroke users.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.